Skip to search formSkip to main contentSkip to account menu

intermedilysin protein, Streptococcus intermedius

Known as: cytolysin ILY, intermedilysin 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

bacteriocin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
The Solvent-Exposed C-Terminus of the Cytolysin A Pore-Forming Toxin Directs Pore Formation and Channel Function in Membranes.
Pore-forming toxins (PFTs) bind to cell membranes and form nanoscale pores that allow leakage of cellular components, resulting… 
2016
2016
Rapid conditional targeted ablation model for hemolytic anemia in the rat.
Effective methods for cell ablation are important tools for examining the anatomical, functional, and behavioral consequences of… 
2014
2014
The diversity of receptor recognition in cholesterol‐dependent cytolysins
Cholesterol‐dependent cytolysins (CDCs) are bacterial pore‐forming toxins secreted mainly by pathogenic Gram‐positive bacteria… 
2013
2013
Profiles of ILY, VLY and Sm-hPAF interaction with human CD59.
BACKGROUND The molecular features of a new member of the bacterially -derived cytolysin family were examined. In particular, the… 
2009
2009
Identification of the high affinity binding site in the Streptococcus intermedius toxin intermedilysin for its membrane receptor, the human complement regulator CD59
2006
2006
Molecular dynamics of human-specific cytolysin: analysis of membrane binding motif for therapeutic application.
BACKGROUND Intermedilysin (ILY) is a human-specific cytolysin secreted from Streptococcus intermedius. In this study, the dynamic… 
2004
2004
Crystallization and preliminary X-ray analysis of the human-specific toxin intermedilysin.
Intermedilysin is a human-specific toxin from Streptococcus intermedius, which is part of normal human oral flora. The bacterium… 
2004
2004
Structural analysis of human specific cytolysin intermedilysin aiming application to cancer immunotherapy.
BACKGROUND Intermedilysin (ILY) is a human specific cytolysin secreted by Streptococcus intermedius. In the present study, we… 
2004
2004
A cell membrane modification technique using domain 4 of intermedilysin for immunotherapy against cancer.
Rapid cell membrane modification techniques are currently being sought in order to develop gene therapy and cellular… 
1997
1997
Intermedilysin. A cytolytic toxin specific for human cells of a Streptococcus intermedius isolated from human liver abscess.
Streptococcus intermedius is one of the three distinct species classified into the Streptococcus milleri-group(SMG, S. anginosus… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)